APOE and diabetic cardiomyopathy: In the cardiovascular system, the disruption of cardiac Alox12/15 attenuates atherosclerosis in apo E-deficient mice [50,51] and attenuates cardiac inflammation in mice with severe transverse aortic constriction [36] and diabetic cardiomyopathy [37].